4//SEC Filing
Fonstein Michael 4
Accession 0001144204-11-016391
CIK 0001318641other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:43 PM ET
Size
8.8 KB
Accession
0001144204-11-016391
Insider Transaction Report
Form 4
Fonstein Michael
DirectorCEO, President
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-03-21+149,609→ 149,609 totalExercise: $7.16From: 2011-03-21Exp: 2021-03-20→ Common Stock (149,609 underlying)
Holdings
- 105,000
Employee Stock Options (Right to Buy)
Exercise: $3.44From: 2010-05-18Exp: 2020-05-17→ Common Stock (105,000 underlying) - 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying) - 137,250
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying)
Footnotes (1)
- [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Fonstein per the 2010 Executive Compensation Plan.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001369806
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:43 PM ET
- Size
- 8.8 KB